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Objectives: During consultations, teenagers regularly ask “why do I have cystic
ﬁbrosis and not my brother or my sister?” “Will my children also have CF?”
Speaking about fertility is not easy for parents: At what age? How? It is also
difﬁcult for health caregivers.
Methods: For answering these crucial questions, we created a pedagogic tool
with some disconnected clothespins, of different colours. The tool also includes
6 pictures, one represents a father, another represents a mother and the other 4
represent babies. During the session of therapeutic education, we ask teenagers
what they know about transmission of their disease, and then we give them correct
information, helped by this tool. So, they can understand the notion of chance
and exclude the parents’ culpability. The pedagogic tool allows explications about
genetic transmission. Teenagers often ask questions about the transmission to their
future children. They understand that determination of spouse’s genetic status will
be essential. For health caregivers, this moment is an opportunity to speak about
fertility and introduce possibilities of medically assisted conception.
Conclusion: Comprehension of genetic transmission of the disease is facilitated by
GENOUTIL. Difﬁculties in fertility can be discussed a long time before the age
of having a child, which is better psychologically. The best moment for using this
GENOUTIL is probably around 12−13 years, before adolescence. Other adapted
circumstances are with parents of a screened baby, to help them explain the disease
transmission to their family, and adults CF patients considering having a baby. This
tool is easy to build and inexpensive.
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Young people with CF are expected to consider infection risk when making deci-
sions about careers, leisure and social activities and avoid environments associated
with increased risk. This study investigated the process by which such decisions
are made.
Seven vignettes were written with a consultant microbiologist, each containing at
least one decision about exposure to an environment associated with increased risk
of infection, but in the context of a potentially desirable activity. For example, one
described a situation in which a patient is asked by a friend to go horse riding,
which would increase risk of exposure to Aspergillus. A further choice (to visit
stables) would increase risk.
Young people with CF (n = 8) were asked to make the choices within each vignette,
and to verbally describe their reasoning as they did so. Conversations were recorded
and subjected to thematic analysis.
The vignettes contained 12 choices involving increased risk. The high risk decision
was made on 61% of occasions. Two choices, involving increased risk to Pseu-
domonas aeruginosa and MRSA, were made by all participants. In making decisions
participants described balancing quality of life with risk to health. Participants
generally demonstrated poor understanding of their own infection status and the
speciﬁc nature of the infections, with none able to accurately describe Burkholderia
cepacia complex. Concern about increased risk of infection was seldom a deciding
factor in decision making but misconceptions held about level of risk meant
participants were rarely making an informed decision.
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Objective: To obtain HRQoL and health state utility values for adult patients with
CF and chronic PA infection.
Methods: Patients taking nebulized or oral antibiotics were recruited from 5
CF centres in UK. They were classiﬁed at study entry by their exacerbation
status: acute pulmonary exacerbation (APE) treated in hospital (severe), treated at
home (mild) or no exacerbation (none). All patients completed the Cystic Fibrosis
Quality of Life-Revised (CFQ-R) and EuroQol-5D (EQ-5D).
Results: Data was collected on 94 patients, 51% male, mean(SD): age 28.5(8.2) yrs;
FEV1 58.7(26.8)%. Among these patients, 17 had a severe APE, 13 had a mild
APE, 58 had no APE and for 6 the information was missing. CFQ-R scores reported
according to APE status showed that the worse the exacerbation status, the lower
the mean CFQ-R scores for the 12 domains and the poorer the quality of life
(exceptions on ‘eating disturbance’ and ‘digestion’). Similar ﬁndings were shown
for the EQ-5D utility and VAS mean scores conﬁrming that patients with more
severe APEs have poorer HRQoL. EQ-5D utility means (95%CI, beta distribution)
were 0.58 (0.42, 0.73) for severe APE, 0.78 (0.65, 0.89) for mild APE, and 0.84
(0.80, 0.88) for those with no APE. For comparison the mean UK general population
norms (age 25−44 is 0.94−0.91).
Conclusions: In CF patients with chronic PA infection the APE status inﬂuences
HRQoL as measured by CFQ-R and EQ-5D. As exacerbation status worsens patients
experience worse HRQoL.
This study was supported by Novartis and preliminary results were presented at the
ERS 2010.
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Background: This review aimed to evaluate research on communication and
information about reproductive and sexual health (RSH) in cystic ﬁbrosis (CF).
Methods: All papers in the English language reporting reproductive and sexual
health issues in CF, published between January 2000 and December 2010 were
included. The review focused on (a) the content of information given to parents
and patients; (b) the sources of information for parents and patients; (c) the timing
of information; (d) health care professionals’, patients’ and parents’ emotional
reactions and attitudes toward communicating about RSH and (e) cultural and
ethical considerations.
Results: Eleven papers were identiﬁed. The study populations were: male patients
(5 papers), female patients (1 paper), mixed sample of male and female patients
(1 paper), health care professionals (1 paper), mixed sample of parents and female
patients (2 papers) and parents of male patients (1 paper). Patients with CF and
their parents express embarrassment to initiate a discussion about RSH. They also
express the need for more speciﬁc and up-to-date verbal and written information,
at appropriate time points, provided by the CF team and infertility specialists.
Healthcare providers also express embarrassment and a need for training to counsel
patients in RSH.
Conclusion: Pro-active discussion of RSH issues with patients and reproductive
counselling is proposed to be a standard part of the care-path. A list of recommen-
dations is given to ensure that patients and parents receive the information they
need.
